Patents by Inventor Kazuo Chihara

Kazuo Chihara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for diabetes
    Patent number: 8569232
    Abstract: Disclosed are method for treating diabetes, a protein for treatment of diabetes, and pharmaceutical composition comprising the same. The protein is human mature chemerin, which can be used to treat diabetes, in particular type 2 diabetes, inter alia to treat diabetes in a patient who is concurrently administered with insulin.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: October 29, 2013
    Assignees: Kobe University, JCR Pharmaceuticals Co., Ltd.
    Inventors: Yutaka Takahashi, Kazuo Chihara
  • THERAPEUTIC AGENT FOR DIABETES
    Publication number: 20110046055
    Abstract: Disclosed are method for treating diabetes, a protein for treatment of diabetes, and pharmaceutical composition comprising the same. The protein is human mature chemerin, which can be used to treat diabetes, in particular type 2 diabetes, inter alia to treat diabetes in a patient who is concurrently administered with insulin.
    Type: Application
    Filed: October 17, 2008
    Publication date: February 24, 2011
    Applicants: KOBE UNIVERSITY, JCR PHARMACEUTICALS CO., LTD.
    Inventors: Yutaka Takahashi, Kazuo Chihara
  • Mutant human growth hormones and their uses
    Patent number: 6238915
    Abstract: In accordance with the present invention, there are provided mutant human growth hormone proteins which exhibit enhanced affinity for growth hormone but lowered hormone activity, base sequences encoding the same and their production processes as well as uses of said proteins. The proteins according to the present invention, with their enhanced affinities for the growth hormone receptor, can inhibit the binding of growth hormone to its receptor, while they retain lowered growth hormone activities, thus finding application as a medicament for the treatment of acromegaly and gigantism.
    Type: Grant
    Filed: February 12, 1997
    Date of Patent: May 29, 2001
    Assignee: JCR Pharmaceuticals Co., Ltd.
    Inventor: Kazuo Chihara